Milad Alucozai

Milad Alucozai is a highly accomplished neuroscientist, entrepreneur, and investor with nearly two decades of experience translating scientific and technological breakthroughs into commercial ventures. He has co-founded multiple biotech companies, including Pamir Ventures and Revalia Bio, and has played key roles in the growth and success of numerous startups in the life sciences and deep tech sectors. harvard+4

His expertise lies at the intersection of bioengineering, computational biology, and machine learning, particularly in accelerating drug discovery and development. He is a co-host of the 'Code to Cure' series at the Wyss Institute, which explores the convergence of AI, biology, and healthcare, and is involved in pioneering human data trials at Revalia Bio. harvard+1

Milad is an active early-stage investor, having backed over 50 startups across North America and Europe, often as the first investor in high-growth companies like Seqera Labs. He has held significant investment roles at BoxOne Ventures and Entrepreneur First, contributing to the development of robust venture capital landscapes. harvard+4

He is a distinguished academic, holding degrees from Purdue University (B.S. Neuroscience, Phi Beta Kappa), Maynooth University (M.P.H. in Immunology and Public Health as a George J. Mitchell Scholar), and the Richard M. Fairbanks School of Public Health (Doctorate). He also served as a Macklin Fellow at Johns Hopkins Medicine and a Visiting Scholar at the Wyss Institute and Purdue's Regenstrief Center. harvard+5

Beyond his professional roles, Milad is committed to mentorship and humanitarian efforts. He has been recognized as a 'Mentor of the Year' at Creative Destruction Lab, and has participated in humanitarian projects globally, using film as a medium to share important stories. creativedestructionlab+1